130 related articles for article (PubMed ID: 9326761)
1. Prevention of experimental autoimmune uveoretinitis by intrathymic S-antigen injection.
Koevary SB; Caspi RR
Ocul Immunol Inflamm; 1997 Sep; 5(3):165-72. PubMed ID: 9326761
[TBL] [Abstract][Full Text] [Related]
2. The effects of pertussis toxin on the induction and transfer of experimental autoimmune uveoretinitis.
McAllister CG; Vistica BP; Sekura R; Kuwabara T; Gery I
Clin Immunol Immunopathol; 1986 May; 39(2):329-36. PubMed ID: 3486070
[TBL] [Abstract][Full Text] [Related]
3. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
Wildner G; Thurau SR
Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
[TBL] [Abstract][Full Text] [Related]
4. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis.
Saoudi A; Hurez V; de Kozak Y; Kuhn J; Kaveri SV; Kazatchkine MD; Druet P; Bellon B
Int Immunol; 1993 Dec; 5(12):1559-67. PubMed ID: 8312226
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of experimental autoimmune uveoretinitis by mercuric chloride injections in (Lewis x Brown Norway) F1 hybrid rats.
Saoudi A; Bellon B; de Kozak Y; Vial MC; Thillaye B; Druet P
Curr Eye Res; 1990; 9 Suppl():135-8. PubMed ID: 2384007
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides.
Vrabec TR; Gregerson DS; Dua HS; Donoso LA
Autoimmunity; 1992; 12(3):175-84. PubMed ID: 1343765
[TBL] [Abstract][Full Text] [Related]
7. Suramin treatment suppresses induction of experimental autoimmune uveoretinitis (EAU) in rodents.
Sartani G; Silver PB; Strassmann G; Chan CC; Caspi RR
Curr Eye Res; 1995 Oct; 14(10):887-96. PubMed ID: 8549154
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
9. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease.
Saoudi A; Kuhn J; Huygen K; de Kozak Y; Velu T; Goldman M; Druet P; Bellon B
Eur J Immunol; 1993 Dec; 23(12):3096-103. PubMed ID: 8258322
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of intravitreal administration of tresperimus, an immunosuppressive drug, on experimental autoimmune uveoretinitis.
Bousquet E; Camelo S; Leroux les Jardins G; Goldenberg B; Naud MC; Besson-Lescure B; Lebreton L; Annat J; Behar-Cohen F; de Kozak Y
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5414-23. PubMed ID: 21666239
[TBL] [Abstract][Full Text] [Related]
11. Modulation of experimental autoimmune uveoretinitis by adoptive transfer of cells from rats immunized with anti-S-antigen monoclonal antibody.
de Kozak Y; Mirshahi M; Boucheix C; Faure JP
Reg Immunol; 1989; 2(5):311-20. PubMed ID: 2485681
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis.
Ikeda E; Hikita N; Eto K; Mochizuki M
Jpn J Ophthalmol; 1997; 41(6):396-402. PubMed ID: 9509307
[TBL] [Abstract][Full Text] [Related]
13. Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells.
Uchio E; Kijima M; Ishioka M; Tanaka S; Ohno S
Graefes Arch Clin Exp Ophthalmol; 1997 Feb; 235(2):97-102. PubMed ID: 9147958
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
[TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of experimental autoimmune uveoretinitis in HgCl2 injected rats.
Saoudi A; Bellon B; de Kozak Y; Druet P
Curr Eye Res; 1992; 11 Suppl():101-5. PubMed ID: 1424735
[TBL] [Abstract][Full Text] [Related]
16. Regulation of retinal autoimmunity via the idiotypic network.
de Kozak Y
Curr Eye Res; 1990; 9 Suppl():193-200. PubMed ID: 1696533
[TBL] [Abstract][Full Text] [Related]
17. Prevention of experimental autoimmune uveoretinitis and experimental autoimmune pinealitis in (Lewis x Brown-Norway) F1 rats by HgCl2 injections.
Saoudi A; Bellon B; de Kozak Y; Kuhn J; Vial MC; Thillaye B; Druet P
Immunology; 1991 Oct; 74(2):348-54. PubMed ID: 1748484
[TBL] [Abstract][Full Text] [Related]
18. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis.
Yotsukura J; Huang H; Singh AK; Shichi H
Cell Immunol; 1997 Dec; 182(2):89-98. PubMed ID: 9514702
[TBL] [Abstract][Full Text] [Related]
19. Experimental autoimmune uveoretinitis (EAU) in rats: abrogation of resistance to the induction and augmentation of the inflammation by pertussis toxin.
Suzuki I; Takahashi S; Fujii Y; Fuyama S; Arai S
Jpn J Ophthalmol; 1989; 33(1):27-35. PubMed ID: 2786590
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.
Yadav UC; Shoeb M; Srivastava SK; Ramana KV
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8033-41. PubMed ID: 21900376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
